SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

HCW Biologics Reports Third Quarter 2026 Business and Clinical Development Highlights and Financial Results

MIRAMAR, Fla., Nov. 16, 2026 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) NASDAQ:HCWB, a clinical-stage biopharmaceutical company focused on developing transformative fusion immunotherapeutics to treat autoimmune diseases, cancer and senescence-associated dysplasia, tod…

HCWB

Related stories